O. Cornely, M. Bassetti, C. T. Garbino, J. Kullberg, B. Lortholary et al., ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clinical Microbiology and Infection, vol.18, pp.19-37, 2012.
DOI : 10.1111/1469-0691.12039

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, . Jr et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-535, 2009.
DOI : 10.1086/596757

R. Sabino, C. Verissimo, J. Brandao, C. Alves, H. Parada et al., Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital, Medical Mycology, vol.49, issue.2, pp.346-354, 2010.
DOI : 10.1111/j.1439-0507.2006.01198.x

N. Sipsas, R. Lewis, J. Tarrand, R. Hachem, K. Rolston et al., Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007), Cancer, vol.5, issue.20, pp.4745-4752, 2001.
DOI : 10.3201/eid1006.030873

J. Zirkel, H. Klinker, A. Kuhn, M. Abele?horn, D. Tappe et al., blood stream infections in patients with hematological malignancies or solid tumors, Medical Mycology, vol.91, issue.1, pp.50-55, 2012.
DOI : 10.1128/JCM.00920-10

M. Gamaletsou, T. Walsh, T. Zaoutis, M. Pagoni, M. Kotsopoulou et al., A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies, Clinical Microbiology and Infection, vol.20, issue.1, pp.50-57, 2014.
DOI : 10.1111/1469-0691.12312

O. Cornely, B. Gachot, H. Akan, M. Bassetti, O. Uzun et al., Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031), Clinical Infectious Diseases, vol.61, issue.3, pp.324-331, 2015.
DOI : 10.1056/NEJMoa066906

O. Lortholary, M. Desnos?ollivier, K. Sitbon, C. Renaudat, S. Bretagne et al., Characteristics of candidemia in oncology differ from those in hematology: a prospective study over a decade, 2016.

S. Bretagne, C. Renaudat, M. Desnos?ollivier, K. Sitbon, and O. Lortholary, Dromer F, on behalf of the French Mycosis Study Group (2017) Predispos? ing factors and outcome of uncommon yeast species?related fungaemia based on an exhaustive surveillance programme, J Antimicrob Chemother, 2002.

O. Lortholary, M. Desnos?ollivier, K. Sitbon, A. Fontanet, S. Bretagne et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, pp.532-538, 2011.
DOI : 10.1128/AAC.01128-10

M. Arendrup, J. Guinea, M. Cuenca?estrella, J. Meletiadis, J. Mouton et al., EUCAST?AFST (2015) EUCAST technical note on the EUCAST definitive document EDef 7.3: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts, 2017.

, Flucona? zole: rationale for the clinical breakpoints, version 2, European Committee on Antibiotic Susceptibility Testing, 2013.

M. Desnos?ollivier, S. Bretagne, D. Raoux, D. Hoinard, F. Dromer et al., Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing, European Committee on Antibiotic Susceptibility Testing, pp.3092-3098, 2008.
DOI : 10.1128/AAC.00088-08

M. Puig?asensio, B. Padilla, J. Garnacho?montero, O. Zaragoza, J. Aguado et al., Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain, Clinical Microbiology and Infection, vol.20, issue.4, pp.245-254
DOI : 10.1111/1469-0691.12380

D. Kontoyiannis, K. Marr, B. Park, B. Alexander, E. Anaissie et al., Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001???2006: Overview of the Transplant???Associated Infection Surveillance Network (TRANSNET) Database, overview of the Transplant?Associated Infection Surveillance Network (TRANSNET) Database, pp.1091-1100, 2001.
DOI : 10.1086/651263

C. Chen, S. Huang, W. Tsay, M. Yao, J. Tang et al., Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001???2010, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.533-538, 2001.
DOI : 10.1016/j.ijantimicag.2012.07.022

L. Pagano, M. Caira, A. Candoni, M. Offidani, L. Fianchi et al., The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM?2004 study, Haema? tologica, vol.91, pp.1068-1075, 2006.

D. Bitar, O. Lortholary, L. Strat, Y. Nicolau, J. Coignard et al., Population?based analysis of invasive fungal infections, Emerg Infect Dis, vol.20, pp.1149-1155, 2001.

B. Almirante, D. Rodriguez, B. Park, M. Cuenca?estrella, A. Planes et al., Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population? based surveillance, Barcelona Candidemia Project Study Group J Clin Microbiol, vol.43, pp.1829-1835, 2002.

R. Hachem, H. Hanna, D. Kontoyiannis, Y. Jiang, and I. Raad, The changing epidemiology of invasive candidiasis, Cancer, vol.37, issue.11, pp.2493-2499, 2008.
DOI : 10.3201/eid1006.030873

D. Horn, D. Neofytos, E. Anaissie, J. Fishman, W. Steinbach et al., Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry, Clinical Infectious Diseases, vol.48, issue.12, pp.1695-1703, 2009.
DOI : 10.1086/599039

P. Munoz, M. Giannella, C. Fanciulli, J. Guinea, M. Valerio et al., Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital, Clinical Microbiology and Infection, vol.17, issue.10, pp.1538-1545, 2011.
DOI : 10.1111/j.1469-0691.2010.03338.x

S. Dufresne, K. Marr, E. Sydnor, J. Staab, J. Karp et al., Epidemiology of Candida kefyr in Patients with Hematologic Malignancies, Journal of Clinical Microbiology, vol.52, issue.6, pp.1830-1837, 2014.
DOI : 10.1128/JCM.00131-14

H. Nace, D. Horn, and D. Neofytos, Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007, Diagnostic Microbiology and Infectious Disease, vol.64, issue.3, pp.289-294, 2004.
DOI : 10.1016/j.diagmicrobio.2009.03.010

J. Chow, Y. Golan, R. Ruthazer, A. Karchmer, Y. Carmeli et al., in the Intensive Care Unit, Clinical Infectious Diseases, vol.9, issue.8, pp.1206-1213, 2008.
DOI : 10.1007/s10096-002-0822-1

D. Rodriguez, B. Almirante, M. Cuenca?estrella, J. Rodriguez?tudela, J. Mensa et al., Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain, Clinical Microbiology and Infection, vol.16, issue.11, pp.1676-1682, 2010.
DOI : 10.1111/j.1469-0691.2010.03208.x

M. Schuster, A. Meibohm, L. Lloyd, and B. Strom, Risk factors and outcomes of Candida krusei bloodstream infection: A matched, case-control study, Journal of Infection, vol.66, issue.3, pp.278-284, 2013.
DOI : 10.1016/j.jinf.2012.11.002

M. Slavin, T. Sorrell, D. Marriott, K. Thursky, Q. Nguyen et al., Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death, Journal of Antimicrobial Chemotherapy, vol.13, issue.10, pp.1042-1051
DOI : 10.3109/13693780802549594

C. Viscoli, C. Girmenia, A. Marinus, L. Collette, P. Martino et al., Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC), Clinical Infectious Diseases, vol.28, issue.5, pp.1071-1079, 1999.
DOI : 10.1086/514731

O. Leroy, S. Bailly, J. Gangneux, J. Mira, P. Devos et al., Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study, Annals of Intensive Care, vol.29, issue.12, 2016.
DOI : 10.1007/s00134-003-2002-x

URL : https://hal.archives-ouvertes.fr/hal-01259216

D. Andes, N. Safdar, J. Baddley, G. Playford, A. Reboli et al., Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials, Clinical Infectious Diseases, vol.51, issue.3, pp.1110-1122, 2012.
DOI : 10.1086/653935

H. Tang, W. Liu, H. Lin, and C. Lai, Epidemiology and Prognostic Factors of Candidemia in Cancer Patients, PLoS ONE, vol.61, issue.6, p.99103, 2014.
DOI : 10.1371/journal.pone.0099103.t003

URL : https://doi.org/10.1371/journal.pone.0099103

A. Cleveland, M. Farley, L. Harrison, B. Stein, R. Hollick et al., Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011, Clinical Infectious Diseases, vol.49, issue.2, pp.1352-1361, 2008.
DOI : 10.3109/13693786.2010.512300

URL : https://academic.oup.com/cid/article-pdf/55/10/1352/922240/cis697.pdf

S. Bailly, O. Leroy, P. Montravers, J. Constantin, H. Dupont et al., Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data, Intensive Care Medicine, vol.18, issue.11, pp.1931-1940, 2015.
DOI : 10.1186/cc13953

URL : https://hal.archives-ouvertes.fr/hal-01205360

M. Zilberberg, M. Kollef, H. Arnold, A. Labelle, S. Micek et al., Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study, BMC Infectious Diseases, vol.12, issue.1, p.150, 2010.
DOI : 10.1186/cc6212

URL : http://doi.org/10.1186/1471-2334-10-150

A. Labelle, S. Micek, N. Roubinian, and M. Kollef, Treatment-related risk factors for hospital mortality in Candida bloodstream infections*, Critical Care Medicine, vol.36, issue.11, pp.2967-2972, 2008.
DOI : 10.1097/CCM.0b013e31818b3477

M. Pai, R. Turpin, and K. Garey, Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia, Antimicrobial Agents and Chemotherapy, vol.51, issue.1, pp.35-39, 2007.
DOI : 10.1128/AAC.00474-06

M. Kollef, S. Micek, N. Hampton, J. Doherty, and A. Kumar, Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control, Clinical Infectious Diseases, vol.331, issue.20, pp.1739-1746, 2012.
DOI : 10.1056/NEJM199411173312001

K. Garey, M. Rege, M. Pai, D. Mingo, K. Suda et al., Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi???Institutional Study, Clinical Infectious Diseases, vol.1, issue.1, pp.25-31, 2006.
DOI : 10.1099/jmm.0.45856-0